Drug Search Results
More Filters [+]

Levcromakalim

Alternative Names: levcromakalim
Latest Update: 2024-05-10
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ATP-sensitive potassium channel Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous,Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Danish Headache Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Levcromakalim

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ILIM

N/A

Recruiting

Migraine with Aura|Headache Disorders|Migraine Disorders|Migraine without Aura

2025-01-01

SLIM

N/A

Recruiting

Headache Disorders|Migraine with Aura|Migraine Disorders|Migraine without Aura

2025-01-01

Glibenclamide H-18052188

N/A

Unknown status

Headache

2023-08-30

H-21028500

N/A

Recruiting

Epilepsy|Headache Disorders|Migraine Disorders|Migraine with Aura|Migraine without Aura

2023-07-31

Recent News Events